Mutant ‘Drivers’ Of Meningiomas Identified By Genomic Sequencing

Mutant 'Drivers' Of Meningiomas Identified By Genomic Sequencing

Large-scale genomic sequencing has revealed two DNA mutations that appear to drive about 15 percent of brain tumors known as meningiomas, a finding that could lead to the first effective drug treatments for the tumors, report scientists from Dana-Farber Cancer Institute and the Broad Institute. Surgery and radiation currently are the only treatments for meningiomas - slow-growing, often benign tumors that develop in the membranes surrounding the brain. Meningiomas can grow dangerously large, however, causing seizures and limb weakness, and occasionally are fatal... (Source: Health News from Medical News Today)

MedWorm Sponsor Message: Have a look at The Cancer and Oncology Daily, the new cancer portal with all the latest cancer news and research powered by MedWorm, updated daily.

View Source